Thomas T. van Sloten
About
Thomas T. van Sloten is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health.
According to data from OpenAlex, Thomas T. van Sloten has authored 91 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Cardiology and Cardiovascular Medicine, 17 papers in Pulmonary and Respiratory Medicine and 16 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Thomas T. van Sloten's work include Cardiovascular Health and Disease Prevention (31 papers), Blood Pressure and Hypertension Studies (18 papers) and Cerebrovascular and Carotid Artery Diseases (15 papers). Thomas T. van Sloten is often cited by papers focused on Cardiovascular Health and Disease Prevention (31 papers), Blood Pressure and Hypertension Studies (18 papers) and Cerebrovascular and Carotid Artery Diseases (15 papers). Thomas T. van Sloten collaborates with scholars based in Netherlands, France and Australia. Thomas T. van Sloten's co-authors include Coen D.A. Stehouwer, Lenore J. Launer, Ronald M.A. Henry, Miranda T. Schram, Sanaz Sedaghat, Mercedes R. Carnethon, Sytze P. Rensma, Pierre Boutouyrie, Jean‐Philippe Empana and Joost Dekker and has published in prestigious journals such as JAMA, Journal of the American College of Cardiology and American Journal of Psychiatry.
In The Last Decade
Thomas T. van Sloten
87 papers receiving 3.2k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Thomas T. van Sloten Netherlands | 29 | 1.4k | 589 | 522 | 471 | 452 | 91 | 3.3k | ||
| Yeseon Park Moon United States | 30 | 777 0.6× | 440 0.7× | 350 0.7× | 913 1.9× | 266 0.6× | 62 | 2.7k | ||
| Sanaz Sedaghat United States | 24 | 639 0.5× | 324 0.6× | 503 1.0× | 289 0.6× | 269 0.6× | 64 | 2.3k | ||
| Richard G. Hutchinson United States | 33 | 1.8k 1.3× | 626 1.1× | 506 1.0× | 484 1.0× | 723 1.6× | 46 | 4.3k | ||
| Michael F. James South Africa | 38 | 1.2k 0.9× | 401 0.7× | 282 0.5× | 379 0.8× | 185 0.4× | 151 | 4.8k | ||
| Chris Moran Australia | 27 | 578 0.4× | 165 0.3× | 645 1.2× | 557 1.2× | 349 0.8× | 124 | 3.2k | ||
| Thorleif Etgen Germany | 25 | 663 0.5× | 333 0.6× | 279 0.5× | 669 1.4× | 127 0.3× | 57 | 2.8k | ||
| Claudia L. Satizábal United States | 30 | 519 0.4× | 300 0.5× | 971 1.9× | 412 0.9× | 191 0.4× | 122 | 3.4k | ||
| Antonio Granata Italy | 35 | 872 0.6× | 912 1.5× | 494 0.9× | 187 0.4× | 345 0.8× | 253 | 4.7k | ||
| David Lefkowitz United States | 24 | 1.4k 1.0× | 1.2k 2.1× | 282 0.5× | 798 1.7× | 293 0.6× | 41 | 3.5k | ||
| Ismo Räihä Finland | 31 | 883 0.6× | 256 0.4× | 603 1.2× | 384 0.8× | 305 0.7× | 89 | 3.5k |
Countries citing papers authored by Thomas T. van Sloten
Since
Specialization
Citations
This map shows the geographic impact of Thomas T. van Sloten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas T. van Sloten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas T. van Sloten more than expected).
Fields of papers citing papers by Thomas T. van Sloten
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Thomas T. van Sloten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas T. van Sloten. The network helps show where Thomas T. van Sloten may publish in the future.
Co-authorship network of co-authors of Thomas T. van Sloten
This figure shows the co-authorship network connecting the top 25 collaborators of Thomas T. van Sloten. A scholar is included among the top collaborators of Thomas T. van Sloten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas T. van Sloten. Thomas T. van Sloten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Zuidgeest, Mira G. P., Yared Santa‐Ana‐Téllez, Christine E. Hallgreen, et al.. (2025). The impact of operational trial approaches on representativeness: Comparison of decentralized clinical trial participants, conventional trial participants, and patients in daily practice. Drug Discovery Today. 30(2). 104304–104304.
2.
Visseren, Frank L.J., Marianne C. Verhaar, Daniël H. van Raalte, et al.. (2025). Effectiveness and safety of combining SGLT2 inhibitors and GLP-1 receptor agonists in individuals with type 2 diabetes: a systematic review and meta-analysis of cohort studies. Diabetologia. 69(1). 36–49.
3.
Eliasson, Björn, Hertzel C. Gerstein, Katarina Eeg‐Olofsson, et al.. (2025). Dementia Risk in People With Type 1 Diabetes and Associated Risk Factors: A Nationwide, Register-Based Cohort Study. Diabetes Care. 48(11). 1888–1895.
4.
Singh‐Manoux, Archana, Sèverine Sabia, Sebastian Köhler, et al.. (2025). Genetic variation in the glucagon-like peptide-1 receptor protein encoding region is associated with higher heart rate variability, but not with neurodegeneration of the brain, retina, and peripheral nerves: The Maastricht study. Cardiovascular Diabetology. 24(1). 397–397.
5.
Visseren, Frank L.J., Birgitta K. Velthuis, Ynte M. Ruigrok, et al.. (2025). Arterial stiffness and atherosclerosis and incident cardiovascular events and all‐cause mortality in individuals with manifest cardiovascular disease with and without type 2 diabetes. Diabetic Medicine. 42(9). e70067–e70067.
6.
Prugger, Christof, Marie‐Cécile Perier, Sèverine Sabia, et al.. (2024). Association between changes in cardiovascular health and the risk of multimorbidity: community-based cohort studies in the UK and Finland. The Lancet Regional Health - Europe. 42. 100922–100922.
7.
Hageman, Steven H J, Björn Eliasson, Naveed Sattar, et al.. (2024). Lifetime and 10‐year cardiovascular risk prediction in individuals with type 1 diabetes: The LIFE‐T1D model. Diabetes Obesity and Metabolism. 26(6). 2229–2238.
8.
Mayeux, Richard, Thomas T. van Sloten, Miranda T. Schram, et al.. (2024). The association of sociodemographic factors with total and item-level semantic fluency metrics.. Neuropsychology. 38(7). 665–678.
9.
Stehouwer, Coen D.A., Jacobus F.A. Jansen, Alfons J.H.M. Houben, et al.. (2024). Microvascular Dysfunction and Whole‐Brain White Matter Connectivity: The Maastricht Study. Journal of the American Heart Association. 13(3). e9112–e9112.
10.
Sloten, Thomas T. van, Rachel E. Climie, Xavier Jouven, et al.. (2023). Association of Cardiovascular Health With Risk of Clinically Relevant Depressive Symptoms. JAMA Psychiatry. 80(4). 342–342.
11.
Satizábal, Claudia L., Russell P. Tracy, Sigurður Sigurdsson, et al.. (2023). Associations of plasma NfL, GFAP, and t-tau with cerebral small vessel disease and incident dementia: longitudinal data of the AGES-Reykjavik Study. GeroScience. 46(1). 505–516.
12.
Empana, Jean‐Philippe, Ivan Lerner, Marie‐Cécile Perier, et al.. (2022). Ultrasensitive Troponin I and Incident Cardiovascular Disease. Arteriosclerosis Thrombosis and Vascular Biology. 42(12). 1471–1481.
13.
Machado‐Fragua, Marcos D., Aurore Fayossé, Manasa Shanta Yerramalla, et al.. (2022). Association of Metabolic Syndrome With Incident Dementia: Role of Number and Age at Measurement of Components in a 28-Year Follow-up of the Whitehall II Cohort Study. Diabetes Care. 45(9). 2127–2135.
14.
Sloten, Thomas T. van, et al.. (2022). Neurovascular coupling unit dysfunction and dementia: Retinal measurements as tools to move towards population-based evidence. Frontiers in Endocrinology. 13. 1014287–1014287.
15.
Sloten, Thomas T. van, Patrick C. Souverein, Coen D.A. Stehouwer, & Johanna H. M. Driessen. (2022). Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and risk of depression among older people with hypertension. Journal of Psychopharmacology. 36(5). 594–603.
16.
Stehouwer, Coen D.A., Martin P.J. van Boxtel, Frans R.J. Verhey, et al.. (2021). Association of Type 2 Diabetes, According to the Number of Risk Factors Within Target Range, With Structural Brain Abnormalities, Cognitive Performance, and Risk of Dementia. Diabetes Care. 44(11). 2493–2502.
17.
Jansen, Jacobus F.A., Thomas T. van Sloten, Coen D.A. Stehouwer, et al.. (2020). Interplay of White Matter Hyperintensities, Cerebral Networks, and Cognitive Function in an Adult Population: Diffusion-Tensor Imaging in the Maastricht Study. Radiology. 298(2). 384–392.
18.
Climie, Rachel E., Thomas T. van Sloten, Marie‐Cécile Perier, et al.. (2019). Change in Cardiovascular Health and Incident Type 2 Diabetes and Impaired Fasting Glucose: The Whitehall II Study. Diabetes Care. 42(10). 1981–1987.
19.
Sloten, Thomas T. van, et al.. (2017). Co‐administration of cyclosporine and ticagrelor may lead to a higher exposure to cyclosporine: a case report of a 49‐year‐old man. British Journal of Clinical Pharmacology. 84(1). 208–210.
20.
Sloten, Thomas T. van, Miranda T. Schram, Marcel C. Adriaanse, et al.. (2013). Endothelial dysfunction is associated with a greater depressive symptom score in a general elderly population: the Hoorn Study. Psychological Medicine. 44(7). 1403–1416.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Yeseon Park Moon Breakdown of academic impact, for papers by Sanaz Sedaghat Breakdown of academic impact, for papers by Richard G. Hutchinson Breakdown of academic impact, for papers by Michael F. James Breakdown of academic impact, for papers by Chris Moran Breakdown of academic impact, for papers by Thorleif Etgen Breakdown of academic impact, for papers by Claudia L. Satizábal Breakdown of academic impact, for papers by Antonio Granata Breakdown of academic impact, for papers by David Lefkowitz Breakdown of academic impact, for papers by Ismo Räihä